1 period filed. Holdings below describe the selected month only.
NPORT-P · filed 2026-06-22
1 class of this one portfolio · 1 exchange-listed
| Class ID | Symbol | Status | Security in the master | Type |
|---|---|---|---|---|
| C000148681 | BBC | LINKEDSEC_TICKER | BBCVirtus Biotech Clinical Trials ETF | ETF |
N-PORT Item C.4.a
N-PORT Item C.4.b
as filed
Positions resolved to the master through ISIN, then rolled up through the taxonomy. 94.1% of reported value reaches a classification.
Percentages are of the reported value of positions above ($38.15M), not of the fund’s net assets ($37.33M). The two differ by cash, derivatives filed with no market value, and rounding.
125 positions in this filing
| Issuer↕ | In master | CUSIP / ISIN | Asset | Balance↕ | Value↕ | Weight▲ | Country |
|---|---|---|---|---|---|---|---|
| ATAIBECKLEY INC ATAIBECKLEY INC COM SHS | ATAI | 04650F101 US04650F1012 | EC CORP | 64,337 NS | $267.6K | 0.717% | US |
| SCHOLAR ROCK HOLDING CORP SCHOLAR ROCK HOLDING CORP COM | SRRK | 80706P103 US80706P1030 | EC CORP | 5,888 NS | $274.4K | 0.735% | US |
| CYTOMX THERAPEUTICS INC CYTOMX THERAPEUTICS INC COM | CTMX | 23284F105 US23284F1057 | EC CORP | 65,872 NS | $278.0K | 0.745% | US |
| CYTOKINETICS INC CYTOKINETICS INC COM NEW | CYTK | 23282W605 US23282W6057 | EC CORP | 4,355 NS | $278.6K | 0.746% | US |
| STOKE THERAPEUTICS INC STOKE THERAPEUTICS INC COM | STOK | 86150R107 US86150R1077 | EC CORP | 8,521 NS | $278.8K | 0.747% | US |
| MBX BIOSCIENCES INC MBX BIOSCIENCES INC COM | MBX | 55287L101 US55287L1017 | EC CORP | 9,242 NS | $279.3K | 0.748% | US |
| SOLENO THERAPEUTICS INC SOLENO THERAPEUTICS INC COM | — | 834203309 US8342033094 | EC CORP | 5,306 NS | $280.3K | 0.751% | US |
| UNIQURE NV UNIQURE NV SHS | QURE | 000000000 NL0010696654 | EC CORP | 14,147 NS | $282.2K | 0.756% | NL |
| ROCKET PHARMACEUTICALS INC ROCKET PHARMACEUTICALS INC COM | RCKT | 77313F106 US77313F1066 | EC CORP | 81,418 NS | $283.3K | 0.759% | US |
| IMMUNOVANT INC IMMUNOVANT INC COM | IMVT | 45258J102 US45258J1025 | EC CORP | 10,446 NS | $283.6K | 0.760% | US |
| MEIRAGTX HOLDINGS PLC MEIRAGTX HOLDINGS PLC COM | MGTX | 000000000 KYG596651029 | EC CORP | 30,942 NS | $285.3K | 0.764% | KY |
| PROTAGONIST THERAPEUTICS INC PROTAGONIST THERAPEUTICS INC COM | PTGX | 74366E102 US74366E1029 | EC CORP | 2,894 NS | $286.4K | 0.767% | US |
| DENALI THERAPEUTICS INC DENALI THERAPEUTICS INC COM | DNLI | 24823R105 US24823R1059 | EC CORP | 15,351 NS | $287.4K | 0.770% | US |
| ORIC PHARMACEUTICALS INC ORIC PHARMACEUTICALS INC COM | ORIC | 68622P109 US68622P1093 | EC CORP | 29,424 NS | $290.7K | 0.779% | US |
| PROTHENA CORP PLC PROTHENA CORP PLC SHS | PRTA | 000000000 IE00B91XRN20 | EC CORP | 26,642 NS | $294.7K | 0.789% | IE |
| APOGEE THERAPEUTICS INC APOGEE THERAPEUTICS INC COM | APGE | 03770N101 US03770N1019 | EC CORP | 3,580 NS | $296.7K | 0.795% | US |
| ZYMEWORKS INC ZYMEWORKS INC COM | ZYME | 98985Y108 US98985Y1082 | EC CORP | 10,832 NS | $298.3K | 0.799% | US |
| RAPPORT THERAPEUTICS INC RAPPORT THERAPEUTICS INC COM | RAPP | 75383L102 US75383L1026 | EC CORP | 9,118 NS | $302.1K | 0.809% | US |
| IMMATICS NV IMMATICS NV SHS | IMTX | 000000000 NL0015285941 | EC CORP | 27,490 NS | $302.1K | 0.809% | NL |
| CULLINAN THERAPEUTICS INC CULLINAN THERAPEUTICS INC COM | CGEM | 230031106 US2300311063 | EC CORP | 23,153 NS | $302.1K | 0.809% | US |
| TAYSHA GENE THERAPIES INC TAYSHA GENE THERAPIES INC COM SHS | TSHA | 877619106 US8776191061 | EC CORP | 47,669 NS | $304.6K | 0.816% | US |
| MOONLAKE IMMUNOTHERAPEUTICS MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | MLTX | 61559X104 KY61559X1045 | EC CORP | 18,661 NS | $305.7K | 0.819% | KY |
| BEAM THERAPEUTICS INC BEAM THERAPEUTICS INC COM | BEAM | 07373V105 US07373V1052 | EC CORP | 10,087 NS | $305.9K | 0.819% | US |
| BELITE BIO INC BELITE BIO INC SPONSORED ADS | BLTE | 07782B104 US07782B1044 | EC CORP | 1,952 NS | $310.7K | 0.832% | KY |
| PRECIGEN INC PRECIGEN INC COM | PGEN | 74017N105 US74017N1054 | EC CORP | 74,799 NS | $311.2K | 0.833% | US |
| ABCELLERA BIOLOGICS INC ABCELLERA BIOLOGICS INC COM | ABCL | 00288U106 CA00288U1066 | EC CORP | 76,245 NS | $316.4K | 0.848% | CA |
| IRONWOOD PHARMACEUTICALS INC IRONWOOD PHARMACEUTICALS INC COM CL A | IRWD | 46333X108 US46333X1081 | EC CORP | 77,097 NS | $318.0K | 0.852% | US |
| CELCUITY INC CELCUITY INC COM | CELC | 15102K100 US15102K1007 | EC CORP | 2,621 NS | $318.1K | 0.852% | US |
| BICARA THERAPEUTICS INC BICARA THERAPEUTICS INC COM | BCAX | 055477103 US0554771032 | EC CORP | 14,934 NS | $322.3K | 0.863% | US |
| IMMUNOME INC IMMUNOME INC COM | IMNM | 45257U108 US45257U1088 | EC CORP | 14,102 NS | $323.5K | 0.866% | US |
| MONTE ROSA THERAPEUTICS INC MONTE ROSA THERAPEUTICS INC COM | GLUE | 61225M102 US61225M1027 | EC CORP | 16,922 NS | $324.1K | 0.868% | US |
| LIQUIDIA CORP LIQUIDIA CORP COM NEW | LQDA | 53635D202 US53635D2027 | EC CORP | 8,268 NS | $324.2K | 0.868% | US |
| TERNS PHARMACEUTICALS INC TERNS PHARMACEUTICALS INC COM | — | 880881107 US8808811074 | EC CORP | 6,132 NS | $324.6K | 0.869% | US |
| ANNEXON INC ANNEXON INC COM | ANNX | 03589W102 US03589W1027 | EC CORP | 55,535 NS | $326.0K | 0.873% | US |
| ARCUS BIOSCIENCES INC ARCUS BIOSCIENCES INC COM | RCUS | 03969F109 US03969F1093 | EC CORP | 12,819 NS | $326.9K | 0.876% | US |
| PRAXIS PRECISION MEDICINES INC PRAXIS PRECISION MEDICINES INC COM NEW | PRAX | 74006W207 US74006W2070 | EC CORP | 1,026 NS | $327.1K | 0.876% | US |
| CELLDEX THERAPEUTICS INC CELLDEX THERAPEUTICS INC COM NEW | CLDX | 15117B202 US15117B2025 | EC CORP | 10,032 NS | $329.9K | 0.884% | US |
| AMYLYX PHARMACEUTICALS INC AMYLYX PHARMACEUTICALS INC COM | AMLX | 03237H101 US03237H1014 | EC CORP | 21,068 NS | $337.1K | 0.903% | US |
| SUMMIT THERAPEUTICS INC SUMMIT THERAPEUTICS INC COM | SMMT | 86627T108 US86627T1088 | EC CORP | 15,708 NS | $337.1K | 0.903% | US |
| NEUROGENE INC NEUROGENE INC COM | NGNE | 64135M105 US64135M1053 | EC CORP | 13,193 NS | $344.2K | 0.922% | US |
| XENON PHARMACEUTICALS INC XENON PHARMACEUTICALS INC COM | XENE | 98420N105 CA98420N1050 | EC CORP | 6,264 NS | $351.0K | 0.940% | CA |
| ARRIVENT BIOPHARMA INC ARRIVENT BIOPHARMA INC COM | AVBP | 04272N102 US04272N1028 | EC CORP | 11,300 NS | $351.3K | 0.941% | US |
| PHARVARIS NV PHARVARIS NV COM | PHVS | 000000000 NL00150005Y4 | EC CORP | 11,424 NS | $354.3K | 0.949% | NL |
| VAXCYTE INC VAXCYTE INC COM | PCVX | 92243G108 US92243G1085 | EC CORP | 6,201 NS | $354.9K | 0.951% | US |
| CAPRICOR THERAPEUTICS INC CAPRICOR THERAPEUTICS INC COM NEW | CAPR | 14070B309 US14070B3096 | EC CORP | 10,606 NS | $356.1K | 0.954% | US |
| PALVELLA THERAPEUTICS INC PALVELLA THERAPEUTICS INC COM | PVLA | 697947109 US6979471090 | EC CORP | 2,798 NS | $359.0K | 0.962% | US |
| EDGEWISE THERAPEUTICS INC EDGEWISE THERAPEUTICS INC COM | EWTX | 28036F105 US28036F1057 | EC CORP | 11,685 NS | $361.8K | 0.969% | US |
| COMPASS PATHWAYS PLC COMPASS PATHWAYS PLC SPONSORED ADS | CMPS | 20451W101 US20451W1018 | EC CORP | 40,950 NS | $371.0K | 0.994% | GB |
| ALLOGENE THERAPEUTICS INC ALLOGENE THERAPEUTICS INC COM | ALLO | 019770106 US0197701065 | EC CORP | 182,788 NS | $389.3K | 1.043% | US |
| TECTONIC THERAPEUTIC INC TECTONIC THERAPEUTIC INC COM | TECX | 878972108 US8789721086 | EC CORP | 13,966 NS | $390.6K | 1.046% | US |